# OnCo record sakk-16-00 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/sakk-16-00/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "sakk-16-00", "NCT00030771" ;
  schema:name "SAKK 16/00"@en ;
  schema:alternateName "SAKK 16/00 induction chemoradiation trial"@en, "Preoperative chemoradiotherapy vs chemotherapy alone in stage IIIA/N2 NSCLC"@en ;
  schema:description "A Swiss trial asked whether lung cancer that has reached the lymph nodes in the middle of the chest does better with radiotherapy added to chemotherapy before the operation. It did not, which spared patients a treatment that adds side effects without adding benefit."@en ;
  schema:url <https://onco.cc/trials/sakk-16-00/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00030771>, <https://doi.org/10.1016/S0140-6736(15)60294-X>, <https://pubmed.ncbi.nlm.nih.gov/26275735/> ;
  onco:status "negative" ;
  onco:phase "3" ;
  schema:startDate "2001-04-04" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:sections <https://onco.cc/fronts/radiation/>, <https://onco.cc/fronts/chemotherapy/> ;
  onco:companies <https://onco.cc/companies/swiss-cancer-institute/> ;
  onco:institutions <https://onco.cc/institutions/swiss-cancer-league/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-surgery-radiation-innovation/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-pless-sakk-16-00-induction-chemoradiation-lancet-2015/> .